Monday, Sep 21, 2020 | Last Update : 09:50 AM IST

180th Day Of Lockdown

Maharashtra118801585793332216 Andhra Pradesh6177765307115302 Tamil Nadu5364774812738751 Karnataka5113454048417922 Uttar Pradesh3362942632884771 Delhi2347011981034877 West Bengal2155801870614183 Telangana1713061397001033 Odisha167161133466722 Bihar164224149722855 Assam150349121610528 Kerala12221687341490 Gujarat119088999083271 Rajasthan109088906851293 Haryana103773816901069 Madhya Pradesh97906743981877 Punjab90032658182646 Chhatisgarh7777541111628 Jharkhand6710052807590 Jammu and Kashmir5971138521951 Uttarakhand3713924810460 Goa2678320844327 Puducherry2142816253431 Tripura2069612956222 Himachal Pradesh11190691997 Chandigarh92566062106 Manipur8430653951 Arunachal Pradesh6851496713 Nagaland5306407910 Meghalaya4356234232 Sikkim2119178923 Mizoram15069490
  Business   Companies  03 Aug 2020  India's Wockhardt to supply COVID-19 vaccines to UK

India's Wockhardt to supply COVID-19 vaccines to UK

REUTERS
Published : Aug 3, 2020, 4:27 pm IST
Updated : Aug 3, 2020, 4:27 pm IST

UK government reserved one fill-and-finish production line at Wockhardt subsidiary in Wrexham, Wales for exclusive use for next 18 months

 Wockhardt to supply millions of doses of COVID-19 vaccines to UK. (PTI Photo)
  Wockhardt to supply millions of doses of COVID-19 vaccines to UK. (PTI Photo)

BENGALURU: Indian drugmaker Wockhardt Ltd will supply millions of doses of multiple COVID-19 vaccines to the UK, including the one being developed by AstraZeneca and Oxford University, it said on Monday.

The company has reserved fill-and-finish capacity - the final manufacturing step of putting vaccines into vials or syringes and packaging them - as part of an agreement with the UK government, it said.

 

Shares in Wockhardt jumped 10% after the news in a downcast Mumbai market.

The UK government has also reserved one fill-and-finish production line at a Wockhardt subsidiary in Wrexham, Wales for its exclusive use for the next 18 months to secure supply.

More than 150 vaccines are being developed and tested around the world to stop the pandemic, with 25 in human clinical trials, according to the World Health Organization.

Coronavirus cases globally have crossed 18 million, including more than 688,000 deaths.

Tags: indian drugmaker, wockhardt ltd, vaccine doses, covid-19 vaccines, u, astrazeneca, oxford university, uk government
Location: India, Karnataka, Bengaluru